Oct 10 (Reuters) - Bayer (BAYGn.DE) must pay $78 million to a Pennsylvania man who said he got cancer from using the company's Roundup weedkiller, a state court jury in Philadelphia found on Thursday.

Per CEO Bill Anderson in an interview this week, Bayer will have a decision in months — not years — about whether it will remain the only domestic producer of glyphosate in the U.S.

Bayer (BAYGn.DE) lost a third appeal against U.S. court verdicts that awarded damages to customers blaming their cancers on use of its glyphosate-based weedkillers, leaving the German drugs and ...

The future of Roundup, the world’s most widely used herbicide, hangs in the balance as chemical maker Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) signals it may soon halt production unless it receives ...

Bayer Leverkusen have completed the signing of midfielder Aleix Garcia from Girona. The 26-year-old played an important role as Girona recorded their best league finish, ending the season third in ...

Bayer is making another push to resolve lawsuits linking the popular weedkiller Roundup to cancer, while exploring a bankruptcy filing for its Monsanto agriculture business in case the settlement ...

Bayer BAYN 2.82% faces a payout of $1.56 billion after a Missouri jury found in favor of the plaintiffs who blamed its Roundup weedkiller for causing their cancers. The decision is the fourth in a ...

Bayer’s history is on its website, which acknowledges IG Farben’s production of synthetic rubbers that were vital to the war effort. It accepts that the company depended on thousands of slave ...

Bayer announced this morning it is in the process of moving its 10 regional seed brands over to its Channel Seed brand lineup, effective for 2025. The 10 brands and states or regions where they ...